Dell Technologies, Thomas Henson, Global Business Development Manager AI/analytics two special guests from Pfizer, Mark Soued, VP, Rare Cardiology Franchise Lead and Ola Oyetayo, Director, Next-Gen Diagnosis, Rare Cardiology will discuss how Artificial Intelligence is shaping the life sciences industry, but more importantly, how it's used to diagnose rare diseases. We have a lot of great topics, and we're very excited to share it with you.
Dell EMC – Global Business Development Manager AI/Analytics
Dell EMC – Field Marketing Manager
Pfizer – VP, Rare Cardiology Franchise Lead, Pfizer Rare Disease
Pfizer – Director, Next-gen Diagnosis, Rare Cardiology